Loren Berry

Loren Berry has been working in the pharmaceutical industry since 1998. Their work experience includes Research Scientist I at Pfizer from 1998 to 2003, Scientist I at Novartis Institutes for BioMedical Research (NIBR) from 2003 to 2005, Scientist and Sr. Associate Scientist at Amgen from 2005 to 2018, Operations Manager at Shire from 2018 to 2019, and Principal Scientist and Sr. Scientist at FORMA Therapeutics, Inc. from 2019 to 2022. Currently, they are the Director of DMPK at Skyhawk Therapeutics.

Loren Berry attended Trinity College-Hartford from 1993 to 1997, where they earned a Bachelor of Science in Neuroscience.